PPH
VanEck Pharmaceutical ETF
1W: +0.4%
1M: -7.4%
3M: -0.0%
YTD: -1.0%
1Y: +12.7%
3Y: +44.9%
5Y: +62.7%
$101.96
-0.68 (-0.66%)
After Hours: $102.50 (+0.54, +0.52%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$606M
Holdings25
Top 10 Wt73.0%
Beta0.54
% Profitable63%
Coverage100%
Portfolio Valuation
P/E16.5
P/B1.3
P/S1.4
EV/EBITDA11.8
P/FCF7.7
PEG0.93
Profitability & Returns
Gross Margin54.2%
Net Margin8.5%
ROE7.6%
ROA3.4%
ROIC5.9%
Div Yield2.46%
Leverage & Liquidity
Debt/Equity0.70
Debt/Assets0.32
Net Debt/EBITDA2.3x
Interest Cov3.7x
Current Ratio1.03
Quick Ratio0.61
Growth (YoY)
Revenue+14.5%
Net Income+49.2%
EPS+50.9%
FCF+58.9%
EBITDA+43.4%
Rev CAGR 3Y+10.1%
Quality Scores
Piotroski F7.0
Altman Z4.86
IS Quality73.5
IS Overall64.2
IS Value46.7
Median P/E19.1
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 25 | 99.6% | 16.7 |
| Other | 2 | 0.4% | — |
Smart Money Overlap
3 holdings with signals
Showing 27 of 27 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 17.97% | $238.6M | 259,941 | 39.1 | $865.9B | Healthcare |
| 2 | Novartis Ag | NVS | 11.04% | $146.6M | 978,735 | 20.5 | $291.4B | Healthcare |
| 3 | Merck & Co Inc | MRK | 9.80% | $130.1M | 1,136,119 | 16.2 | $295.1B | Healthcare |
| 4 | Pfizer Inc | PFE | 5.15% | $68.4M | 2,504,658 | 20.2 | $155.3B | Healthcare |
| 5 | Bristol-Myers Squibb Co | BMY | 5.07% | $67.4M | 1,134,799 | 17.2 | $120.0B | Healthcare |
| 6 | Johnson & Johnson | JNJ | 5.03% | $66.8M | 281,365 | 21.7 | $578.2B | Healthcare |
| 7 | Mckesson Corp | MCK | 4.95% | $65.8M | 71,470 | 24.6 | $108.6B | Healthcare |
| 8 | Novo Nordisk A/S | NVO | 4.80% | $63.8M | 1,703,192 | 10.3 | $161.5B | Healthcare |
| 9 | Gsk Plc | GSK | 4.71% | $62.5M | 1,200,440 | 14.4 | $110.5B | Healthcare |
| 10 | Astrazeneca Plc | AZN.L | 4.49% | $59.6M | 316,182 | 27.6 | $218.1B | Healthcare |
| 11 | Abbvie Inc | ABBV | 4.05% | $53.8M | 258,065 | 88.8 | $366.3B | Healthcare |
| 12 | Sanofi Sa/France | SNY | 3.96% | $52.6M | 1,204,168 | 9.3 | $112.1B | Healthcare |
| 13 | Cencora Inc | COR | 3.86% | $51.3M | 157,721 | 38.0 | $63.2B | Healthcare |
| 14 | Zoetis Inc | ZTS | 3.29% | $43.6M | 371,870 | 19.2 | $51.4B | Healthcare |
| 15 | Haleon Plc | HLN | 3.10% | $41.1M | 3,986,999 | 21.7 | $43.5B | Healthcare |
| 16 | Takeda Pharmaceutical Co Ltd | TAK | 3.02% | $40.1M | 2,226,667 | 81.0 | $57.8B | Healthcare |
| 17 | Teva Pharmaceutical Industries Ltd | TEVA | 2.50% | $33.2M | 1,121,181 | 23.8 | $34.3B | Healthcare |
| 18 | Viatris Inc | VTRS | 0.83% | $11.1M | 805,990 | -4.4 | $15.5B | Healthcare |
| 19 | Jazz Pharmaceuticals Plc | JAZZ | 0.68% | $9.0M | 50,016 | -32.5 | $11.6B | Healthcare |
| 20 | Elanco Animal Health Inc | ELAN | 0.48% | $6.3M | 255,657 | -53.2 | $12.7B | Healthcare |
| 21 | Axsome Therapeutics Inc | AXSM | 0.43% | $5.7M | 36,316 | -45.5 | $8.3B | Healthcare |
| 22 | Other/Cash Cash | — | 0.27% | $3.6M | — | — | — | — |
| 23 | Corcept Therapeutics Inc | CORT | 0.17% | $2.2M | 66,029 | 40.2 | $4.3B | Healthcare |
| 24 | -USD CASH- Cash | — | 0.11% | $1.5M | 1,469,318 | — | — | — |
| 25 | Organon & Co | OGN | 0.10% | $1.3M | 203,331 | 8.4 | $1.6B | Healthcare |
| 26 | Bausch Health Cos Inc | BHC.TO | 0.08% | $1.1M | 213,715 | 12.2 | $2.6B | Healthcare |
| 27 | Perrigo Co Plc | 0Y5E.L | 0.06% | $816,442 | 82,137 | -0.9 | $1.4B | Healthcare |